These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The toxicity of tri-o-cresyl phosphate for rats as related to dietary casein level, vitamin E and vitamin A. HOVE EL J Nutr; 1953 Dec; 51(4):609-22. PubMed ID: 13118399 [No Abstract] [Full Text] [Related]
5. Observations on the specificity of the inhibition of cholinesterases by tri-orthocresyl phosphate. EARL CJ; THOMPSON RH; WEBSTER GR Br J Pharmacol Chemother; 1953 Mar; 8(1):110-4. PubMed ID: 13066705 [No Abstract] [Full Text] [Related]
6. [Inhibitory activities of tri-ortho-cresyl phosphate (TOCP) against cholinesterase and neurotoxic esterase]. Kawai M; Iyatomi A; Kaneko Y Sangyo Igaku; 1984 Jan; 26(1):68-9. PubMed ID: 6482069 [No Abstract] [Full Text] [Related]
7. Tri-o-cresyl phosphate as a vitamin E antagonist for the rat and lamb. DRAPER HH; JAMES MF; JOHNSON BC J Nutr; 1952 Aug; 47(4):583-99. PubMed ID: 14955712 [No Abstract] [Full Text] [Related]
8. An outbreak of tri-ortho-cresyl phosphate (T.O.C.P.) poisoning in Durban. SUSSER M; STEIN Z Br J Ind Med; 1957 Apr; 14(2):111-20. PubMed ID: 13426434 [No Abstract] [Full Text] [Related]
9. [The pathogenic importance of primitive muscular degeneration in the late stages of intoxication due to tri-ortho-cresyl phosphate]. WALTHARD KM Schweiz Med Wochenschr; 1947 May; 77(22-23):599-603. PubMed ID: 20245103 [No Abstract] [Full Text] [Related]
11. Assessment of neurotoxic effects of tri-cresyl phosphates (TCPs) and cresyl saligenin phosphate (CBDP) using a combination of in vitro techniques. Hausherr V; Schöbel N; Liebing J; van Thriel C Neurotoxicology; 2017 Mar; 59():210-221. PubMed ID: 27288108 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of the cholinesterase of the central nervous system by organophosphorus compounds. DAVISON AN Biochem J; 1953 Jun; 54(3):xix-xx. PubMed ID: 13058939 [No Abstract] [Full Text] [Related]
13. SOLVENT toxicity relation with protein and vitamin A and E. Nutr Rev; 1954 Jun; 12(6):179-80. PubMed ID: 13166146 [No Abstract] [Full Text] [Related]
15. Prevention of the androgenic effects of testosterone propionate by ali-esterase inhibition. MYERS DK; SIMONS SP Biochem J; 1953 Feb; 53(3):xvii. PubMed ID: 13037663 [No Abstract] [Full Text] [Related]
16. Increased serum corticosterone levels in triorthotolyl phosphate-treated chickens. Foil L; Satterlee D; Jacobs-Perry L Bull Environ Contam Toxicol; 1985 Jun; 34(6):780-6. PubMed ID: 4016286 [No Abstract] [Full Text] [Related]
17. Healthy F-16 pilots show no evidence of exposure to tri-ortho-cresyl phosphate through the on-board oxygen generating system. Tacal O; Schopfer LM Chem Biol Interact; 2014 May; 215():69-74. PubMed ID: 24661946 [TBL] [Abstract][Full Text] [Related]
18. Involvement of neuropathy target esterase in tri-ortho-cresyl phosphate-induced testicular spermatogenesis failure and growth inhibition of spermatogonial stem cells in mice. Chen JX; Xu LL; Mei JH; Yu XB; Kuang HB; Liu HY; Wu YJ; Wang JL Toxicol Lett; 2012 May; 211(1):54-61. PubMed ID: 22450445 [TBL] [Abstract][Full Text] [Related]
19. The elimination of ortho-tricresyl phosphate in the milk. MOKRANJAC M; RADMIC S Acta Pharm Jugosl; 1954; 4(1):20-4. PubMed ID: 13188716 [No Abstract] [Full Text] [Related]
20. [The effect of tri-o-cresyl phosphate on the endocrine system]. HEGYVARY C; CSALAY L Kiserl Orvostud; 1963 Jun; 15():275-9. PubMed ID: 13953324 [No Abstract] [Full Text] [Related] [Next] [New Search]